121 related articles for article (PubMed ID: 32196612)
1. MiR-429-5p attenuates the migration and invasion of malignant melanoma by targeting LIMK1.
Sheng H; Guo YH; Cao DS; Li XJ; Zhao Y; Ding H; Zhang YL; Chen ZH
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2625-2631. PubMed ID: 32196612
[TBL] [Abstract][Full Text] [Related]
2. MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1.
Zhou J; Liu R; Luo C; Zhou X; Xia K; Chen X; Zhou M; Zou Q; Cao P; Cao K
Cancer Biol Ther; 2014 Oct; 15(10):1340-9. PubMed ID: 25019203
[TBL] [Abstract][Full Text] [Related]
3. miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma.
Li J; Liu X; Li C; Wang W
J Cell Biochem; 2019 Aug; 120(8):12412-12421. PubMed ID: 30825222
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA hsa_circ_0012673 facilitates lung cancer cell proliferation and invasion via miR-320a/LIMK18521 axis.
Qin H; Liu J; Du ZH; Hu R; Yu YK; Wang QA
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1841-1852. PubMed ID: 32141553
[TBL] [Abstract][Full Text] [Related]
5. MiR-135b-5p inhibits the progression of malignant melanoma cells by targeting RBX1.
Zhang XH; Xin ZM
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1309-1315. PubMed ID: 32096167
[TBL] [Abstract][Full Text] [Related]
6. MiR-125b-5p Inhibitor Might Protect Against Sevoflurane-induced Cognitive Impairments by Targeting LIMK1.
Xiong J; Wang H; Mu F; Liu Z; Bao Y; Sun Y
Curr Neurovasc Res; 2019; 16(4):382-391. PubMed ID: 31490755
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of Limk1 caused by microRNA-138 loss aggravates the metastasis of ovarian cancer by activation of Limk1/cofilin signaling.
Chen P; Zeng M; Zhao Y; Fang X
Oncol Rep; 2014 Nov; 32(5):2070-6. PubMed ID: 25190487
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of miR-106a targets LIMK1 and contributes to cognitive impairment induced by isoflurane anesthesia in mice.
Zhang N; Ye W; Wang T; Wen H; Yao L
Genes Genomics; 2020 Apr; 42(4):405-412. PubMed ID: 31933141
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-125a-5p targets LIM kinase 1 to inhibit cisplatin resistance of cervical cancer cells.
Xu Y; Zheng Y; Duan Y; Ma L; Nan P
Oncol Lett; 2021 May; 21(5):392. PubMed ID: 33777215
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma.
Liang L; Zhang Z; Qin X; Gao Y; Zhao P; Liu J; Zeng W
Melanoma Res; 2019 Dec; 29(6):569-581. PubMed ID: 30889053
[TBL] [Abstract][Full Text] [Related]
11. miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1.
Xia H; Sun S; Wang B; Wang T; Liang C; Li G; Huang C; Qi D; Chu X
Int J Mol Sci; 2014 Jul; 15(7):11973-83. PubMed ID: 25003638
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of miR-93 and inhibition of LIMK1 improve ventricular remodeling and alleviate cardiac dysfunction in rats with chronic heart failure by inhibiting RhoA/ROCK signaling pathway activation.
Su Q; Zhang P; Yu D; Wu Z; Li D; Shen F; Liao P; Yin G
Aging (Albany NY); 2019 Sep; 11(18):7570-7586. PubMed ID: 31541994
[TBL] [Abstract][Full Text] [Related]
13. [miR-590-5p inhibits A375 cell invasion and migration in malignant melanoma by directly inhibiting YAP1 expression].
Wang L; Shi S; Zhou Y; Mu X; Han D; Ge R; Mu K
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Mar; 33(3):326-330. PubMed ID: 28274310
[TBL] [Abstract][Full Text] [Related]
14. MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1.
Li D; Song H; Wu T; Xie D; Hu J; Zhao J; Shen Q; Fang L
Mol Cell Biochem; 2018 Jul; 444(1-2):169-178. PubMed ID: 29188531
[TBL] [Abstract][Full Text] [Related]
15. Metabolites of intestinal microflora upregulate miR-192-5p to suppress proliferation of colon cancer cells via RhoA-ROCK-LIMK2 pathway.
Huang YL; Li XH; Ma H; Yue HY; Hu XY
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1794-1806. PubMed ID: 32141548
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-28-5p regulates glioma cell proliferation, invasion and migration by targeting SphK1.
Chen HS; Lu AQ; Yang PY; Liang J; Wei Y; Shang YW; Li Q
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6621-6628. PubMed ID: 31378904
[TBL] [Abstract][Full Text] [Related]
17. MiR-338-5p promotes the growth and metastasis of malignant melanoma cells via targeting CD82.
Long J; Luo J; Yin X
Biomed Pharmacother; 2018 Jun; 102():1195-1202. PubMed ID: 29710538
[TBL] [Abstract][Full Text] [Related]
18. Sevoflurane induces cognitive impairments via the MiR-27b/LIMK1-signaling pathway in developing rats.
Yu Y; Zhang P; Yan J; Sun Y; Wu X; Xi S; Zhang L; Sun Y; Hu R; Jiang H
Inhal Toxicol; 2016 Dec; 28(14):731-738. PubMed ID: 27973945
[TBL] [Abstract][Full Text] [Related]
19. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
Su BB; Zhou SW; Gan CB; Zhang XN
J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway.
Cai S; Chen R; Li X; Cai Y; Ye Z; Li S; Li J; Huang H; Peng S; Wang J; Tao Y; Huang H; Wen X; Mo J; Deng Z; Wang J; Zhang Y; Gao X; Wen X
Oncotarget; 2015 Feb; 6(6):3904-17. PubMed ID: 25714010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
